GMED Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
12.1%
Last Quarter
$1.18
Past Year
$3.09
Growth Past 5yrs
-13.26%
Next Quarter
$1.08
Estimate Next Year
$18.35
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$114.00
31.22% Upside
Mean Price Target
$91.20
4.97% Upside
Lowest Price Target
$64.00
-26.34% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
GMED Earnings Per Share (EPS) History
According to financial reports, GMED (NYSE: GMED) reported an actual EPS of $1.18 for the quarter ending on Nov 06, 2025, compared to an estimated $0.79, resulting in a 49.37% surprise. In the prior quarter (Aug 07, 2025), GMED recorded an actual EPS of $0.86 with a 13.16% surprise. See GMED's full earnings history.
Earnings History
EPS Surprise Factor Analysis
GMED has experienced notable EPS surprises, with the latest quarter ending Nov 06, 2025 showing a 49.37% beat. Previously, the quarter ending Aug 07, 2025 recorded a 13.16% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
Frequently Asked Questions
Is GMED stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given GMED stock an average recommendation of
Buy. 20 analysts have given their ratings
to GMED out of which
9 analysts have given strong buy call,
7 analysts have given buy call,
4 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$91.20 gives the stock implied upside
of roughly 4.97% over the next year or so.
What have analysts suggested for GMED highest price target?
Analysts suggest GMED's stock price would rise to a high of $114.00.
What is the lowest price target analysts expect for GMED over the next year?
Within the next 12 months, analysts predict the GMED stock price could move to $64.00.
What is the average target price for GMED?
GMED stock has an average analyst estimate of $91.20.
At its current price, how far is GMED from its average target price?
GMED shares are currently trading 4.97% above this price target.
What were GMED’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $1.18 versus consensus estimates of $0.79, and above the comparable year-ago quarter’s EPS of $0.38.
What are the current estimates for quarterly and annual earnings per share?
GMED's forecasts by analysts estimating quarterly EPS at $1.08 and $18.35 for the whole year.
What has GMED's growth been in the past five years and what is expected in the next five years?
The analysts have projected 12.1% EPS growth for GMED in the next five years, compared to growth rates of -13.26% in the past five years.